These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15863811

  • 1. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR, Carter C, Goldman R, Green MF, Marder SR, Xie H, Schooler NR, Kane JM.
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [Abstract] [Full Text] [Related]

  • 2. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia.
    McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R.
    Schizophr Res; 2004 Jun 01; 68(2-3):225-33. PubMed ID: 15099605
    [Abstract] [Full Text] [Related]

  • 3. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P.
    Psychiatry Res; 2008 Sep 30; 160(3):316-26. PubMed ID: 18579217
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL, Harris MS, Keshavan MS, Sweeney JA.
    Arch Gen Psychiatry; 2006 Nov 30; 63(11):1189-97. PubMed ID: 17088499
    [Abstract] [Full Text] [Related]

  • 5. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 30; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
    Savina I, Beninger RJ.
    Schizophr Res; 2007 Aug 30; 94(1-3):128-38. PubMed ID: 17560766
    [Abstract] [Full Text] [Related]

  • 7. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V, Taboada D, Aragüés M, Hernández JA, Sanz-Fuentenebro J.
    Schizophr Res; 2014 Sep 30; 158(1-3):223-9. PubMed ID: 25088730
    [Abstract] [Full Text] [Related]

  • 8. Clozapine improves working memory updating in schizophrenia.
    Galletly CA, Clark CR, McFarlane AC.
    Eur Neuropsychopharmacol; 2005 Dec 30; 15(6):601-8. PubMed ID: 15905072
    [Abstract] [Full Text] [Related]

  • 9. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA.
    Am J Psychiatry; 2005 Jan 30; 162(1):130-6. PubMed ID: 15625211
    [Abstract] [Full Text] [Related]

  • 10. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
    Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J.
    Am J Psychiatry; 1997 Jun 30; 154(6):799-804. PubMed ID: 9167507
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.
    Am J Psychiatry; 2001 Aug 30; 158(8):1305-13. PubMed ID: 11481167
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S, Pourcher E, Cohen H.
    J Int Neuropsychol Soc; 2008 Jan 30; 14(1):110-8. PubMed ID: 18078537
    [Abstract] [Full Text] [Related]

  • 13. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T, Cudkowicz ME, Sexton PM, Growdon JH.
    J Neuropsychiatry Clin Neurosci; 2000 Jan 30; 12(3):364-9. PubMed ID: 10956570
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J, Nolan KA, Kline L, Czobor P, Citrome L, Sheitman B, Lindenmayer JP, McEvoy J, Lieberman JA.
    Schizophr Res; 2005 Jul 01; 76(1):127-9. PubMed ID: 15927808
    [No Abstract] [Full Text] [Related]

  • 15. Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task.
    Lim EP, Verma V, Nagarajah R, Dawe GS.
    Psychopharmacology (Berl); 2007 Apr 01; 191(2):297-310. PubMed ID: 17225165
    [Abstract] [Full Text] [Related]

  • 16. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.
    Han M, Zhang XY, Chen DC, Tan YL, Song CS, Yu YH, Huang XF.
    Int Clin Psychopharmacol; 2015 Mar 01; 30(2):89-95. PubMed ID: 25568968
    [Abstract] [Full Text] [Related]

  • 17. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.
    Manschreck TC, Redmond DA, Candela SF, Maher BA.
    J Neuropsychiatry Clin Neurosci; 1999 Mar 01; 11(4):481-9. PubMed ID: 10570762
    [Abstract] [Full Text] [Related]

  • 18. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group.
    N Engl J Med; 2006 Feb 02; 354(5):472-82. PubMed ID: 16452559
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
    Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA.
    Neuropsychopharmacology; 2008 Feb 02; 33(3):465-72. PubMed ID: 17487227
    [Abstract] [Full Text] [Related]

  • 20. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR, Marder SR, Chengappa KN, Petrides G, Ames D, Wirshing WC, McMeniman M, Baker RW, Parepally H, Umbricht D, Kane JM.
    J Clin Psychiatry; 2016 May 02; 77(5):628-34. PubMed ID: 27035871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.